Saline stretch: could a Fluid-Filled injection unfreeze stiff shoulders?

NCT ID NCT06493656

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study compares two injection treatments for frozen shoulder (adhesive capsulitis). One group receives a standard steroid injection, while the other gets the same steroid plus extra saline to gently stretch the shoulder capsule. Researchers will measure pain, range of motion, and shoulder function over six months to see if the added fluid helps restore movement better than steroid alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
corticosteroid injection with or without saline hydrodilatation
What this could lead to
If hydrodilatation proves superior, it could become a standard, non-surgical treatment for frozen shoulder, offering better mobility without more invasive procedures.
What could go wrong
This is a small, early-stage trial with only 50 participants. The diluted steroid may provide less pain relief, and results may not apply to all frozen shoulder cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Dec 2013

Finished

Nov 2015

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

35 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Two or more of the following criteria within the shoulder's range of motion: * Abduction and forward elevation below 100˚ * External rotation at the side below 30˚ * Internal rotation at 90˚ of abduction below 30˚ Exclusion Criteria: * History of shoulder surgery, trauma, nerve injury * Concomitant rotator cuff/biceps lesions in ultrasound or MRI * Glenohumeral arthritis in simple X-ray * Calcific tendinosis in simple X-ray * Underlying conditions: cancer, mental illness, hormonal imbalance * Diabetes with HbA1c levels exceeding 7.0%

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwondo, 700-204, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.